Application
Application
Abu Raniya
a. Providing the best catalyst in the form of improved organism usually a microbe or enzyme.
APPLICATIONS IN AGRICULTURE
3 options for increasing food production:
a. Agro-chemical based agriculture: It uses fertilizers & pesticides. Expensive. Causes environmental
pollution.
b. Organic agriculture: Expensive.
c. Genetically engineered crop-based agriculture: It uses genetically modified crops. Genetically Modified
Organisms (GMO) are the plants, bacteria, fungi & animals whose genes are altered by manipulation.
· It makes crops more tolerant to abiotic stresses (cold, drought, salt, heat etc.).
· Pest-resistant crops reduce the use of chemical pesticides.
· It reduces post-harvest losses.
· It increases efficiency of mineral usage by plants (it prevents early exhaustion of soil fertility).
· It enhances nutritional value of food. E.g. Golden rice (Vitamin A enriched rice).
· To create tailor-made plants to supply alternative resources (starches, fuels, pharmaceuticals etc.) to
industries.
Bt Cotton:
- Some strains of Bacillus thuringiensis have proteins that kill insects like coleopterans (beetles), lepidopterans
(tobacco budworm, armyworm) & dipterans (flies, mosquitoes).
- B. thuringiensis forms an insecticidal protein (Bt toxin) crystal during a phase of their growth. It does not kill
the Bacillus as it exists as inactive protoxins.
1/2
- When an insect ingests the toxin, it becomes active due to alkaline pH of the gut which solubilise the crystals.
Toxin binds to surface of mid-gut epithelial cells creating pores. It causes cell swelling and lysis and death of the
insect.
- Bt toxin genes were isolated from B. thuringiensis and incorporated into crop plants such as cotton.
- Most Bt toxins are insect-group specific. They are coded by cry genes. E.g. proteins encoded by cryIAc &
cryIIAb genes control cotton bollworms. Protein of cryIAb gene controls corn borer.
- A nematode Meloidogyne incognita infects the roots of tobacco plants causing a reduction in yield.
- It can be prevented by RNA interference (RNAi) strategy.
- RNAi is a method of cellular defense in all eukaryotic organisms. It prevents translation of a specific mRNA
(silencing) due to a complementary dsRNA molecule.
- The source of this complementary RNA is from an infection by RNA viruses or mobile genetic elements
(transposons) that replicate via an RNA intermediate.
- Isolate Nematode-specific genes (DNA). It is introduced into host plant using Agrobacterium vectors. It
produces both sense & anti-sense RNA in host cells. These RNAs are complementary. So they form double
stranded (ds) RNA. It initiates RNAi and silences the specific mRNA of nematode. Thus the parasite cannot
survive in a transgenic host expressing specific interfering RNA.
============
2/2
Biotechnology and Its Applications - Notes | Class 12 |
Part 2: Applications in Medicine
bankofbiology.com/2020/07/biotechnology-and-its-applications_28.html
Abu Raniya
APPLICATIONS IN MEDICINE
- Recombinant DNA technology helps for mass production of safe and more effective therapeutic drugs.
- Products from non-human sources cause unwanted immunological responses. But recombinant therapeutics
does not have such problems.
- At present, about 30 recombinant therapeutics have been approved. Of these, 12 are being marketed in India.
- Insulin from the pancreas of animals (cattle & pigs) causes allergy or other types of reactions to the foreign
protein.
- Insulin consists of two short polypeptide chains (chain A & chain B) that are linked by disulphide bridges.
1/3
- The pro-hormone contains an extra stretch called C peptide. This is removed during maturation into insulin.
- In 1983, Eli Lilly (an American company) prepared two DNA sequences corresponding to A & B chains of
human insulin and introduced them in plasmids of E. coli to produce insulin chains. Chains A & B were
combined by creating disulfide bonds to form human insulin (Humulin).
2. Gene Therapy
- Here, genes are inserted into a person’s cells and tissues to treat a hereditary disease. It compensates for the
non-functional gene.
- First clinical gene therapy (1990) was given to a 4-year old girl with adenosine deaminase (ADA) deficiency.
- This is caused due to the deletion of a gene of adenosine deaminase (an enzyme for the functioning of
immune system). It can be cured by bone marrow transplantation orby enzyme replacement therapy
(injection of ADA). But these are not completely curative.
- Gene therapy for ADA deficiency: Collect lymphocytes from the patient’s blood and grow in a culture →
Introduce a functional ADA cDNA into lymphocytes (using a retroviral vector) → They are returned to the
patient.
- If the ADA gene from marrow cells is introduced into cells at early embryonic stages, it could be a permanent
cure.
3. Molecular Diagnosis
- Conventional methods (serum & urine analysis) are not suitable for early diagnosis of diseases.
2/3
- Presence of a pathogen is normally suspected only based on symptoms. By this time, the concentration of
pathogen is already very high in the body.
- However, very low concentration of a bacteria or virus can be detected by amplification of their nucleic acid by
PCR.
- Uses of PCR:
- A single stranded DNA or RNA, tagged with a radioactive molecule (probe) is hybridized to its complementary
DNA in a clone of cells. It is detected by autoradiography. The clone having mutated gene will not appear on
photographic film, because the probe will not have complementarity with mutated gene.
- Infection by pathogen can be detected by the presence of antigens (proteins, glycoproteins, etc.) or by
detecting the antibodies synthesized against the pathogen.
============
3/3
Biotechnology and Its Applications - Notes | Class 12 |
Part 3: Transgenic Animals, Ethical Issues
bankofbiology.com/2020/07/biotechnology-and-its-applications_79.html
Abu Raniya
TRANSGENIC ANIMALS
- These are the animals whose genome has been altered by introduction of a foreign gene by manipulation.
· To study regulation of genes and their action on normal physiology & development: E.g. Study of
insulin-like growth factor. Genes (from other species) that alter formation of this factor are introduced and the
biological effects are studied. This gives information about biological role of the factor.
· To study the contribution of genes in the development of a disease and thereby new treatments: E.g.
transgenic models for human diseases such as cancer, cystic fibrosis, rheumatoid arthritis & Alzheimer’s.
· Biological products: Some medicines contain expensive biological products. Transgenic animals can be used
to produce biological products by introducing genes which codes for a particular product.
They are used to treat diseases such as emphysema, phenylketonuria (PKU), cystic fibrosis etc. E.g. human
protein (a-1-antitrypsin) used to treat emphysema.
In 1997, Rosie (first transgenic cow) produced human protein-enriched milk (2.4 gm per litre). It contains
human a-lactalbumin. It is nutritionally more balanced product for human babies than natural cow-milk.
· Vaccine safety testing: Transgenic mice are used to test the safety of the polio vaccine. If it is reliable, they
can replace the use of monkeys to test the safety of vaccines.
· Chemical safety testing (toxicity testing): Some transgenic animals carry genes which make them more
sensitive to toxic substances than non-transgenic animals. They are exposed to the toxic substances and the
effects studied. It gives immediate results.
ETHICAL ISSUES
1/2
· Problem of unpredictable results: Genetic modification may cause unpredictable results.
Indian Government has set up organizations like GEAC (Genetic Engineering Approval Committee) to make
decisions about the validity of GM research and the safety of GM-organisms for public services.
· Bio-piracy: Itis the use of bio-resources by multinational companies and other organizations without proper
authorization from the countries and people concerned. Certain companies have got patents for products and
technologies that make use of the genetic materials, plants etc. that have been identified, developed and used
by farmers and indigenous people of a country. E.g. Basmati rice, herbal medicines (turmeric, neem etc.).
Basmati rice has unique aroma & flavour. India has 27 varieties of Basmati. In 1997, an American company got
patent rights on Basmati rice through the US Patent and Trademark Office. This allowed the company to sell a
‘new’ variety of Basmati. This was actually derived from Indian farmer’s varieties. Indian Basmati was crossed
with semi-dwarf varieties and claimed as a novelty. Other people selling Basmati rice could be restricted by
patent.
Generally, industrialized nations are poor in biodiversity and traditional knowledge. The developing and
underdeveloped world have rich biodiversity and traditional knowledge related to bio-resources.
It has to develop laws to prevent unauthorized exploitation of bio-resources and traditional knowledge.
Indian Parliament has cleared the second amendment of the Indian Patents Bill that has considered patent
terms emergency provisions and research and development initiative.
============
2/2